Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Defective pharyngeal development protein 4 (PHA-4) is a highly conserved transcription factor of the Forkhead box A (FOXA) family found in Caenorhabditis elegans[3][4][5]. PHA-4 functions as a master regulator of organogenesis for the pharynx and rectum during embryogenesis, with expression predominantly in the developing pharynx across all its cell types[3][4]. It directly binds DNA to control the expression of key developmental genes and acts as a central regulator integrating environmental cues, such as dietary restriction, to control gene networks impacting longevity, metabolism, stress resistance, and lipid homeostasis[1][2][5][7]. PHA-4 mediates complex feed-forward loops, regulating both protein-coding genes and microRNAs, especially under energetic stress[1][2]. Although extensively studied for its roles in development and aging, it is not a direct therapeutic target and has no approved drug modulators, though the related human FOXA factors have roles in metabolism and cancer[2][4][5][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Defective pharyngeal development protein 4 (PHA-4).